{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.ai-analytics.org/drug-product/67184-1001#drug","name":"Cefazolin","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"67184-1001"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"ANDA203661"},{"@type":"PropertyValue","propertyID":"UNII","value":"P380M0454Z"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"e8bd9e95-8af5-416b-b58c-e1dbe3d052ac"}],"activeIngredient":"CEFAZOLIN SODIUM","administrationRoute":["INTRAMUSCULAR","INTRAVENOUS"],"dosageForm":"INJECTION, POWDER, FOR SOLUTION","manufacturer":{"@type":"Organization","name":"Qilu Pharmaceutical Co., Ltd."},"drugClass":[],"isAvailableGenerically":true,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.ai-analytics.org/drug-approval/ANDA203661","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e8bd9e95-8af5-416b-b58c-e1dbe3d052ac","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=67184-1001"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","data_provider_url":"https://api.ai-analytics.org","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-09-27T12:07:00.710Z"}}